Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2

NCT03283007 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Lung-transplant Recipients

Interventions

DRUG: Nintedanib
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris